Table 1 Clinical information of TCGA-COAD 450Â K datasets
Characteristics | High-risk | Low-risk |
|---|---|---|
n | 144 | 145 |
Gender, n (%) | Â | Â |
 Female | 65 (22.5%) | 68 (23.5%) |
 Male | 79 (27.3%) | 77 (26.6%) |
Stage, n (%) | Â | Â |
 Stage I | 16 (5.5%) | 27 (9.3%) |
 Stage III | 56 (19.4%) | 28 (9.7%) |
 Stage II | 40 (13.8%) | 72 (24.9%) |
 Stage IV | 27 (9.3%) | 13 (4.5%) |
 Unknow | 5 (1.7%) | 5 (1.7%) |
T, n (%) | Â | Â |
 T2 | 17 (5.9%) | 25 (8.7%) |
 T4 | 28 (9.7%) | 10 (3.5%) |
 T3 | 95 (32.9%) | 106 (36.7%) |
 T1 | 3 (1%) | 4 (1.4%) |
 Unknow | 1 (0.3%) | 0 (0%) |
M, n (%) | Â | Â |
 M0 | 87 (30.1%) | 110 (38.1%) |
 MX | 27 (9.3%) | 20 (6.9%) |
 M1 | 27 (9.3%) | 13 (4.5%) |
 Unknow | 3 (1%) | 2 (0.7%) |
N, n (%) | Â | Â |
 N0 | 63 (21.8%) | 105 (36.3%) |
 N1 | 50 (17.3%) | 23 (8%) |
 N2 | 31 (10.7%) | 17 (5.9%) |